机构:
Department of Ophthalmology,Fuling Center Hospital of Chongqing City
Department of Ophthalmology,the Second Xiangya Hospital,Central South UniversityDepartment of Ophthalmology,Fuling Center Hospital of Chongqing City
Yu He
[1
,2
]
Song-Bai Jia
论文数: 0引用数: 0
h-index: 0
机构:
Department of Ophthalmology,the Second Xiangya Hospital,Central South UniversityDepartment of Ophthalmology,Fuling Center Hospital of Chongqing City
Song-Bai Jia
[2
]
Wei Zhang
论文数: 0引用数: 0
h-index: 0
机构:
Department of Ophthalmology,Fuling Center Hospital of Chongqing CityDepartment of Ophthalmology,Fuling Center Hospital of Chongqing City
Wei Zhang
[1
]
Jing-Ming Shi
论文数: 0引用数: 0
h-index: 0
机构:
Department of Ophthalmology,the Second Xiangya Hospital,Central South UniversityDepartment of Ophthalmology,Fuling Center Hospital of Chongqing City
Jing-Ming Shi
[2
]
机构:
[1] Department of Ophthalmology,Fuling Center Hospital of Chongqing City
[2] Department of Ophthalmology,the Second Xiangya Hospital,Central South University
Uveitis is one of the most important causes of blindness worldwide.Its etiology and pathogenesis are complicated and have not been well understood.The treatment for uveitis is predominantly based on steroids and immunosuppressants.However,systemic side effects limit their clinical application.With the advancement of molecular biology,some intravitreal implants and biologic agents have been used for the treatment of uveitis.Additionally,novel techniques such as gene therapy and RNA interference are being studied for using as uveitis therapy.This paper reviews recent advances in uveitis treatment.